Evidence map›Paper›PMID 34193208›Full record

ArticleCritical care (London, England)2021

Monocyte distribution width (MDW) performance as an early sepsis indicator in the emergency department: comparison with CRP and procalcitonin in a multicenter international European prospective study.

Pierre Hausfater, Neus Robert Boter, Cristian Morales Indiano, Marta Cancella de Abreu, Adria Mendoza Marin, Julie Pernet, Dolores Quesada, Iris Castro, Diana Careaga, Michel Arock and 2 more

Registry-linked trialOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in Critical care (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03588325 (Evaluation of MDW for Early Detection of Sepsis In the Emergency Department), which is not on this map. Cited by 60 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 3 pooled it
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03588325 completednot on this map

Evaluation of MDW for Early Detection of Sepsis In the Emergency Department

TypeobservationalSponsorBeckman Coulter, Inc.Ran2018 to 2019Enrolled947ConditionsSevere Infection, Sepsis, Severe SepsisArmsCBC-DIFF with MDW, PCT, CRP
3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 3 syntheses or guidelines pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Novel inflammatory biomarkers in the prognosis of COVID-19.Therapeutic advances in respiratory disease
    Pooled it
  4. Trial
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Pierre HausfaterEmergency Department, Hôpital Pitié-Salpêtrière, APHP-Sorbonne Université, 83 Boulevard de l'hôpital, 75651, Paris Cedex 13, France. pierre.hausfater@aphp.fr.ORCID http://orcid.org/0000-0002-7716-6354
Neus Robert BoterEmergency Department, Hospital Universitari Germans Trias I Pujol, Badalona, Spain.
Cristian Morales IndianoUniversitat Autònoma de Barcelona, Badalona, Spain.
Marta Cancella de AbreuEmergency Department, Hôpital Pitié-Salpêtrière, APHP-Sorbonne Université, 83 Boulevard de l'hôpital, 75651, Paris Cedex 13, France.
Adria Mendoza MarinEmergency Department, Hospital Universitari Germans Trias I Pujol, Badalona, Spain.
Julie PernetEmergency Department, Hôpital Pitié-Salpêtrière, APHP-Sorbonne Université, 83 Boulevard de l'hôpital, 75651, Paris Cedex 13, France.
Dolores QuesadaUniversitat Autònoma de Barcelona, Badalona, Spain.
Iris CastroBeckman Coulter, Inc., Miami, FL, USA.
Diana CareagaBeckman Coulter, Inc., Miami, FL, USA.
Michel ArockBiochemisty and Emergency Biology Department, Hôpital Pitié-Salpêtrière, APHP-Sorbonne Université, Paris, France.
Liliana TejidorBeckman Coulter, Inc., Miami, FL, USA.
Laetitia VellyEmergency Department, Hôpital Pitié-Salpêtrière, APHP-Sorbonne Université, 83 Boulevard de l'hôpital, 75651, Paris Cedex 13, France.
Universitat Autònoma de Barcelona · ESBeckman Coulter Foundation · USSorbonne Université · FRUniversité Sorbonne Nouvelle · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly sepsis diagnosis has emerged as one of the main challenges in the emergency room. Measurement of sepsis biomarkers is largely used in current practice to improve the diagnosis accuracy. Monocyte distribution width (MDW) is a recent new sepsis biomarker, available as part of the complete blood count with differential. The objective was to evaluate the performance of MDW for the detection of sepsis in the emergency department (ED) and to compare to procalcitonin (PCT) and C-reactive protein (CRP).

methodsSubjects whose initial evaluation included a complete blood count were enrolled consecutively in 2 EDs in France and Spain and categorized per Sepsis-2 and Sepsis-3 criteria. The performance of MDW for sepsis detection was compared to that of procalcitonin (PCT) and C-reactive protein (CRP).

resultsA total of 1,517 patients were analyzed: 837 men and 680 women, mean age 61 ± 19 years, 260 (17.1%) categorized as Sepsis-2 and 144 patients (9.5%) as Sepsis-3. The AUCs [95% confidence interval] for the diagnosis of Sepsis-2 were 0.81 [0.78-0.84] and 0.86 [0.84-0.88] for MDW and MDW combined with WBC, respectively. For Sepsis-3, MDW performance was 0.82 [0.79-0.85]. The performance of MDW combined with WBC for Sepsis-2 in a subgroup of patients with low sepsis pretest probability was 0.90 [0.84-0.95]. The AUC for sepsis detection using MDW combined with WBC was similar to CRP alone (0.85 [0.83-0.87]) and exceeded that of PCT. Combining the biomarkers did not improve the AUC. Compared to normal MDW, abnormal MDW increased the odds of Sepsis-2 by factor of 5.5 [4.2-7.1, 95% CI] and Sepsis-3 by 7.6 [5.1-11.3, 95% CI].

conclusionsMDW in combination with WBC has the diagnostic accuracy to detect sepsis, particularly when assessed in patients with lower pretest sepsis probability. We suggest the use of MDW as a systematic screening test, used together with qSOFA score to improve the accuracy of sepsis diagnosis in the emergency department. Trial Registration ClinicalTrials.gov (NCT03588325).

Indexed as

AdultAgedAged, 80 and overBiomarkersC-Reactive ProteinEmergency Service, HospitalFemaleHumansMaleMiddle AgedMonocytesProcalcitoninProspective StudiesROC CurveSepsisBiomarkersC-Reactive ProteinProcalcitoninC-reactive proteinEmergency departmentMDWMonocyte volume distribution widthProcalcitoninSepsis

Identifiers

PMID34193208
PMCPMC8247285
OpenAlexW3175449766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.